• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    182.51 Down 2.11(1.14%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:184.62
    Open:184.01
    Bid:177.87 x 100
    Ask:186.00 x 200
    1y Target Est:214.41
    Beta:1.21
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:178.65 - 184.60
    52wk Range:136.37 - 203.30
    Volume:957,422
    Avg Vol (3m):1,257,010
    Market Cap:36.89B
    P/E (ttm):55.98
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 1.14%36.89B
    AMGNDown 0.67%120.32B
    BAXDown 0.77%37.67B

    Key Statistics

    Forward P/E (1 yr):24.93
    P/S (ttm):16.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.91
    Quarterly EPS Est (Mar-15) :1.33
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback